AAAAAA
Results:
1-12
|
Results: 12
Authors:
Ghani, AC
de Wolf, F
Ferguson, NM
Donnelly, CA
Coutinho, R
Miedema, F
Goudsmit, J
Anderson, RM
Citation: Ac. Ghani et al., Surrogate markers for disease progression in treated HIV infection, J ACQ IMM D, 28(3), 2001, pp. 226-231
Authors:
Foudraine, NA
Jurriaans, S
Weverling, GJ
Burger, DM
Hoetelmans, RMW
Roos, MTL
Maas, J
Miedema, F
Reiss, P
Portegies, P
de Wolf, F
Lange, JMA
Citation: Na. Foudraine et al., Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial, ANTIVIR TH, 6(1), 2001, pp. 55-62
Authors:
Nieuwkerk, PT
Sprangers, MAG
Burger, DM
Hoetelmans, RMW
Hugen, PWH
Danner, SA
van der Ende, ME
Schneider, MME
Schrey, G
Meenhorst, PL
Sprenger, HG
Kauffmann, RH
Jambroes, M
Chesney, MA
de Wolf, F
Lange, JMA
Citation: Pt. Nieuwkerk et al., Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study, ARCH IN MED, 161(16), 2001, pp. 1962-1968
Authors:
Fraser, C
Ferguson, NM
Ghani, AC
Prins, JM
Lange, JMA
Goudsmit, J
Anderson, RM
de Wolf, F
Citation: C. Fraser et al., Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs, AIDS, 14(6), 2000, pp. 659-669
Authors:
Gisolf, EH
Jurriaans, S
Pelgrom, J
van Wanzeele, F
van der Ende, ME
Brinkman, K
Borst, MJ
de Wolf, F
Japour, AJ
Danner, SA
Citation: Eh. Gisolf et al., The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine, AIDS, 14(4), 2000, pp. 405-413
Authors:
Putter, H
Prins, JM
Jurriaans, S
Roos, M
Ferguson, NM
van Praag, R
van der Hoek, L
Schuitemaker, H
Anderson, RM
Goudsmit, J
Lange, JMA
de Wolf, F
Citation: H. Putter et al., Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection, AIDS, 14(18), 2000, pp. 2831-2839
Authors:
Gisolf, EH
Enting, RH
Jurriaans, S
de Wolf, F
van der Ende, ME
Hoetelmans, RMW
Portegies, P
Danner, SA
Citation: Eh. Gisolf et al., Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine, AIDS, 14(11), 2000, pp. 1583-1589
Authors:
Grossman, Z
Polis, M
Feinberg, MB
Grossman, Z
Levi, I
Jankelevich, S
Yarchoan, R
Boon, J
de Wolf, F
Lange, JMA
Goudsmit, J
Dimitrov, DS
Paul, WE
Citation: Z. Grossman et al., Ongoing HIV dissemination during HAART, NAT MED, 5(10), 1999, pp. 1099-1104
Authors:
Prins, JM
Jurriaans, S
van Praag, RME
Blaak, H
van Rij, R
Schellekens, PTA
ten Berge, IJM
Yong, SL
Fox, CH
Roos, MTL
de Wolf, F
Goudsmit, J
Schuitemaker, H
Lange, JMA
Citation: Jm. Prins et al., Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy, AIDS, 13(17), 1999, pp. 2405-2410
Authors:
de Jong, JJ
Goudsmit, J
Lukashov, VV
Hillebrand, ME
Baan, E
Huismans, R
Danner, SA
ten Veen, JH
de Wolf, F
Jurriaans, S
Citation: Jj. De Jong et al., Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs, AIDS, 13(1), 1999, pp. 75-80
Authors:
de Baar, MP
van der Horn, KHM
Goudsmit, J
de Ronde, A
de Wolf, F
Citation: Mp. De Baar et al., Detection of human immunodeficiency virus type 1 nucleocapsid protein p7 in vitro and in vivo, J CLIN MICR, 37(1), 1999, pp. 63-67
Authors:
Wit, FWNM
van Leeuwen, R
Weverling, GJ
Jurriaans, S
Nauta, K
Steingrover, R
Schuijtemaker, J
Eyssen, X
Fortuin, D
Weeda, M
de Wolf, F
Reiss, P
Danner, SA
Lange, JMA
Citation: Fwnm. Wit et al., Outcome and predictors of failure of highly active antiretroviral therapy:One-year follow-up of a cohort of human immunodeficiency virus type 1 infected persons, J INFEC DIS, 179(4), 1999, pp. 790-798
Risultati:
1-12
|